Xiaolan Deng

11.8k total citations · 3 hit papers
50 papers, 2.1k citations indexed

About

Xiaolan Deng is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Xiaolan Deng has authored 50 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 12 papers in Cancer Research and 6 papers in Pharmacology. Recurrent topics in Xiaolan Deng's work include RNA modifications and cancer (20 papers), Cancer-related gene regulation (15 papers) and Cancer-related molecular mechanisms research (9 papers). Xiaolan Deng is often cited by papers focused on RNA modifications and cancer (20 papers), Cancer-related gene regulation (15 papers) and Cancer-related molecular mechanisms research (9 papers). Xiaolan Deng collaborates with scholars based in China, United States and Belgium. Xiaolan Deng's co-authors include Jianjun Chen, Rui Su, Huilin Huang, Hengyou Weng, Zejuan Li, Ying Qing, Yusuke Nakamura, David Horne, Minjie Wei and Xuesong Feng and has published in prestigious journals such as Blood, American Journal of Clinical Nutrition and Cancer Research.

In The Last Decade

Xiaolan Deng

47 papers receiving 2.1k citations

Hit Papers

RNA N6-methyladenosine modification in cancers: current s... 2018 2026 2020 2023 2018 2023 2022 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. RNA N6-methyladenosine modification in cancers: current status and perspectives
    2018 610 citations Xiaolan Deng, Rui Su et al. profile →
  2. The roles and implications of RNA m6A modification in cancer
    2023 204 citations Xiaolan Deng, Ying Qing et al. Nature Reviews Clinical Oncology profile →
  3. FTO in cancer: functions, molecular mechanisms, and therapeutic implications
    2022 157 citations Yangchan Li, Rui Su et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolan Deng China 22 1.7k 830 243 210 97 50 2.1k
Xinchun Zhou United States 22 1.1k 0.7× 517 0.6× 62 0.3× 243 1.2× 51 0.5× 62 1.9k
Chen Xue China 31 1.6k 0.9× 1.0k 1.2× 80 0.3× 262 1.2× 144 1.5× 125 2.7k
Guodong Chen China 24 798 0.5× 166 0.2× 54 0.2× 251 1.2× 65 0.7× 123 1.6k
Changqing Yang China 26 776 0.5× 422 0.5× 33 0.1× 201 1.0× 58 0.6× 92 1.7k
Can Chen China 21 552 0.3× 276 0.3× 44 0.2× 172 0.8× 64 0.7× 90 1.3k
Maria Franzini Italy 26 726 0.4× 153 0.2× 64 0.3× 231 1.1× 93 1.0× 92 2.2k
Hui Fu China 18 629 0.4× 224 0.3× 42 0.2× 168 0.8× 87 0.9× 66 1.2k

Countries citing papers authored by Xiaolan Deng

Since Specialization
Citations

This map shows the geographic impact of Xiaolan Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolan Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolan Deng more than expected).

Fields of papers citing papers by Xiaolan Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolan Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolan Deng. The network helps show where Xiaolan Deng may publish in the future.

Co-authorship network of co-authors of Xiaolan Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolan Deng. A scholar is included among the top collaborators of Xiaolan Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolan Deng. Xiaolan Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qin, Xi, Keren Zhou, Yang Lü, et al.. (2025). CRISPR screening reveals ZNF217 as a vulnerability in high-risk B-cell acute lymphoblastic leukemia. Theranostics. 15(8). 3234–3256.
2.
Hu, Xiao, Min Liu, Ming‐Rong Zhang, et al.. (2024). SnoRNAs: The promising targets for anti-tumor therapy. Journal of Pharmaceutical Analysis. 14(11). 101064–101064. 4 indexed citations
3.
Deng, Xiaolan, Ying Qing, David Horne, Huilin Huang, & Jianjun Chen. (2023). The roles and implications of RNA m6A modification in cancer. Nature Reviews Clinical Oncology. 20(8). 507–526. 204 indexed citations breakdown →
4.
Qing, Ying, Wu Dong, Xiaolan Deng, Jianjun Chen, & Rui Su. (2023). RNA Modifications in Cancer Metabolism and Tumor Microenvironment. Cancer treatment and research. 190. 3–24. 3 indexed citations
5.
Zhao, Zhicong, Ying Qing, Xiaolan Deng, Rui Su, & Jianjun Chen. (2023). The roles and therapeutic implications of messenger RNA internal N7‐methylguanosine and N6‐methyladenosine modifications in chemoresistance. Clinical and Translational Medicine. 13(9). e1400–e1400. 1 indexed citations
6.
Deng, Xiaolan, et al.. (2023). The Development of Naringin for Use against Bone and Cartilage Disorders. Molecules. 28(9). 3716–3716. 19 indexed citations
7.
Shen, Chao, Kitty Wang, Xiaolan Deng, & Jianjun Chen. (2022). DNA N6-methyldeoxyadenosine in mammals and human disease. Trends in Genetics. 38(5). 454–467. 37 indexed citations
8.
Han, Li, Keith Leung, Zhicong Zhao, et al.. (2022). Abstract 3617: METTL16 drives leukemogenesis and maintains leukemia stem cell self-renewal via reprogramming BCAA metabolism. Cancer Research. 82(12_Supplement). 3617–3617. 2 indexed citations
9.
Deng, Xiaolan, et al.. (2020). Application and evaluation of multidisciplinary team intervention in super-aged patients with sarcopenia. ˜The œJournal of practical nursing. 36(4). 241–246. 1 indexed citations
10.
Cai, Xiaoyan, et al.. (2020). Effect of a two-way quality feedback nursing model on patients with chronic obstructive pulmonary disease. Annals of Palliative Medicine. 9(5). 3182–3186. 3 indexed citations
11.
Chen, Qiuchen, Xiaolan Deng, Xiao Hu, et al.. (2019). Breast Cancer Risk–Associated SNPs in the mTOR Promoter Form De Novo KLF5- and ZEB1-Binding Sites that Influence the Cellular Response to Paclitaxel. Molecular Cancer Research. 17(11). 2244–2256. 10 indexed citations
12.
Hou, Weigang, Zhaolong Ning, Xiping Hu, et al.. (2018). On-Chip Hardware Accelerator for Automated Diagnosis Through Human–Machine Interactions in Healthcare Delivery. IEEE Transactions on Automation Science and Engineering. 16(1). 206–217. 28 indexed citations
13.
Deng, Xiaolan, et al.. (2018). Critical Enzymatic Functions of FTO in Obesity and Cancer. Frontiers in Endocrinology. 9. 396–396. 108 indexed citations
14.
Deng, Xiaolan, Rui Su, Xuesong Feng, Minjie Wei, & Jianjun Chen. (2017). Role of N6-methyladenosine modification in cancer. Current Opinion in Genetics & Development. 48. 1–7. 165 indexed citations
15.
Deng, Xiaolan & Yusuke Nakamura. (2016). Cancer Precision Medicine: From Cancer Screening to Drug Selection and Personalized Immunotherapy. Trends in Pharmacological Sciences. 38(1). 15–24. 61 indexed citations
16.
Li, Zhenyu, Xiaolan Deng, Weihua Huang, et al.. (2014). Lignans from the bark of Eucommia ulmoides inhibited Ang II-stimulated extracellular matrix biosynthesis in mesangial cells. Chinese Medicine. 9(1). 8–8. 23 indexed citations
17.
Li, Hui, Jing Xian, Xiaolan Deng, & Dongsheng Ouyang. (2013). [Targets of anti-hyperlipidemia drugs].. PubMed. 38(1). 101–8. 2 indexed citations
18.
Chopra, Shruti, Xiaolan Deng, Mei Zhang, et al.. (2013). Analysis of micronomicin by liquid chromatography with pulsed electrochemical detection. Journal of Chromatography A. 1295. 90–98. 8 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xinchun Zhou Breakdown of academic impact, for papers by Chen Xue Breakdown of academic impact, for papers by Guodong Chen Breakdown of academic impact, for papers by Changqing Yang Breakdown of academic impact, for papers by Can Chen Breakdown of academic impact, for papers by Maria Franzini Breakdown of academic impact, for papers by Hui Fu
Rankless by CCL
2026